1011.HK

China NT Pharma Group Company Limited [1011.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

1011.HK Stock Summary

In the News

1011.HK Financial details

Company Rating
-
Market Cap
60.38M
Income
-218.9M
Revenue
405.17M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
16
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
-1.39
Forward P/E
-
PEG
-0.32
P/S
0.66
P/B
-0.38
P/C
-
P/FCF
4.34
Quick Ratio
0.01
Current Ratio
0.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.12
EPS next Y
-
EPS next Q
-
EPS this Y
-56.3%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-43.54%
Revenue last 5Y
-18.37%
Revenue Q/Q
-4.6%
EPS Q/Q
-87.5%
-
-
-
-
SMA20
2.41%
SMA50
8.97%
SMA100
10.39%
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
29%
ROC
-0.11%
Gross Margin
60%
Oper. Margin
9%
Profit Margin
-32%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.017-0.102
52W High
-
52W Low
-
RSI
49.39
Rel Volume
0.04
Avg Volume
8.25M
Volume
305.5K
Perf Week
-4.55%
Perf Month
3.7%
Perf Quarter
37.7%
Perf Half Y
86.67%
-
-
-
-
Beta
-0.967
-
-
Volatility
0.02%, 0.03%
Prev Close
1.2%
Price
0.84
Change
-1.18%

Something similar

Top by Market Cap
BRK-B
GOOG
1YD.DE
MIX.JO
NVDA
Same Sector
HAEK.DE
PDPL.NS
RENE.L
LJPC
ATHX
Same Price Range
1936.HK
1486.HK
0621.HK
GASX.V
IDHC.L
Similar Market Cap
STRAX.ST
HTY
ESON.LS
D4T4.L
FICVU

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 8.25M
  • Market Capitalization 60.38M
  • Employee 16
  • CEO Mr. Tit Ng
  • Headquarters Suzhou,CN
  • IPO Date 2011-04-20
  • Website https://www.ntpharma.com

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.